From eNewsletter 11/11/2020
DID YOU KNOW that a study from Heart and Vessels revealed an association between increased long-term mortality risk and lower levels of coenzyme Q10 (CoQ10)?
The study examined men and women admitted to coronary care units in Japan over a three year period. Those with average or above average CoQ10 had a 52% lower risk of dying from any cause.
It should be noted that patients in the low CoQ10 group were found to be receiving higher doses of statins than those in the normal CoQ10 group. And those who had high levels of CoQ10 levels had much lower C-Reactive Protein, associated with inflammation, compared to those with low levels.
NEXT BIOTRITION FOOD INTOLERANCE TEST DAY - Saturday, 11/14 If you would like to get your blood drawn for the Biotrition Food Intolerance Test, the next scheduled date is Saturday, November 14th. Unless Bonnie has already given you authorization, you need to email her first for permission to get the test. COVID-19 Prevention and Treatment Continue with extra immune support until summer of 2021. SARS-CoV-2 is not going away anytime soon. Moreover, SARS-CoV-2 is not the only virus we fight. There are influenza (flu), norovirus (stomach flu), adenovirus (common cold), and four other coronaviruses (common cold), among others. Prevent and Fight Coronavirus 2.0 is our must-read protocol. COVID-19 Condition Monograph For those interested in conventional and integrative treatments for COVID-19, Steve has written COVID-19 Condition Monograph.
Have a happy, healthy day! Steve and Bonnie
Steve and Bonnie: The early returns on Pfizer's COVID-19 vaccine efficacy is encouraging. We welcome successful, safe vaccines. That said, it may not be until fall of 2021 until a vaccine is distributed to every American. In addition, research shows that SARS-CoV-2 is mutating and scientists are unsure how COVID-19 vaccines will respond. Finally, this vaccine, as well as many others in the pipeline, is introducing an entirely new technology, one in which messenger RNA teaches our immune system to make antibodies to specifically repel SARS-CoV-2. While an incredible feat of science, safety of new technology such as this is paramount.